Oct 12, 2026 07:56AM
Oct 8, 2026 07:34AM
Oct 7, 2026 08:41AM
Sep 23, 2026 08:35AM
Sep 23, 2026 07:59AM
Sep 17, 2026 07:44AM
Sep 11, 2026 08:01AM Clearmind enrolls first AUD patients in CMND-100 trial
Sep 8, 2026 07:43AM
Sep 1, 2026 07:37AM
Aug 24, 2026 08:51AM
Aug 24, 2026 08:05AM
Aug 13, 2026 07:36AM
Aug 6, 2026 08:00AM
Jul 30, 2026 08:30AM Clearmind reports no serious adverse events in CMND-100 dose trial
Jul 28, 2026 07:47AM
Jul 20, 2026 07:55AM
Jul 17, 2026 07:32AM
Jul 16, 2026 09:30AM
Jul 13, 2026 08:17AM
Jul 10, 2026 08:32AM
Jul 7, 2026 07:43AM Clearmind reports MEAI intranasal formulation feasibility study success
Jun 22, 2026 08:07AM
Jun 16, 2026 07:32AM
May 29, 2026 08:41AM
May 26, 2026 08:25AM
May 12, 2026 08:41AM
May 5, 2026 08:53AM
Apr 20, 2026 04:03PM Clearmind Medicine responds to Trump executive order on psychedelic drugs
Apr 20, 2026 07:15AM
Apr 14, 2026 07:32AM
Mar 30, 2026 08:32AM
Mar 17, 2026 09:15AM
Mar 13, 2026 07:46AM
Mar 11, 2026 09:08AM
Mar 10, 2026 08:59AM Clearmind Medicine receives international patent for weight loss therapy
Mar 4, 2026 07:30AM
Feb 19, 2026 04:15PM
Feb 9, 2026 08:17AM
Feb 9, 2026 08:17AM
Feb 9, 2026 08:00AM
Feb 6, 2026 08:02AM
Feb 6, 2026 07:57AM Polyrizon partners with Clearmind to develop intranasal MEAI formulation
Jan 14, 2026 08:55AM
Dec 24, 2025 09:15AM
Dec 16, 2025 08:45AM
Dec 5, 2025 05:01PM
Dec 2, 2025 07:57AM
Dec 1, 2025 08:57AM
Nov 26, 2025 04:18PM Clearmind Medicine (CMND) files for 5.78M share offering by selling stockholders
Nov 25, 2025 07:17AM

466,930 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All